|
|
|
|
|
Sponsored by: |
Triangle Pharmaceuticals |
Information provided by: | NIH AIDS Clinical Trials Information Service |
ClinicalTrials.gov Identifier: | NCT00002362 |
This study will look at whether emtricitabine is as safe and effective as abacavir (ABC) when taken with stavudine (d4T) and efavirenz (EFV) in patients who have never taken anti-HIV drugs.
Condition | Intervention | Phase |
HIV Infections |
Drug: Abacavir sulfate Drug: Efavirenz Drug: Emtricitabine Drug: Stavudine |
Phase III |
MedlinePlus related topics: | AIDS AIDS Medicines |
ChemIDplus related topics: | Abacavir Abacavir sulfate Stavudine Efavirenz |
Study Type: | Interventional |
Study Design: | Treatment, Safety Study |
Official Title: | A Randomized, Open-Label Superiority Trial Comparing Emtricitabine to Abacavir Within a Triple Drug Combination in Antiretroviral-Drug Naive HIV-1 Infected Patients |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria
You may be eligible if you:
Exclusion Criteria
You will not be eligible if you:
United States, California | |||||
San Francisco Veterans Administration Med Ctr | |||||
San Francisco, California, United States, 94121 | |||||
Ctr for AIDS Research / Education and Service (CARES) | |||||
Sacramento, California, United States, 95814 | |||||
United States, Florida | |||||
Gary Richmond MD | |||||
Fort Lauderdale, Florida, United States, 33316 | |||||
United States, Illinois | |||||
Northstar Med Clinic | |||||
Chicago, Illinois, United States, 60657 | |||||
United States, New Jersey | |||||
South Jersey Infectious Diseases Inc | |||||
Somers Point, New Jersey, United States, 08244 | |||||
United States, New York | |||||
North Shore Univ Hosp / Div of Infectious Diseases | |||||
Manhasset, New York, United States, 11030 | |||||
United States, Texas | |||||
Univ of Texas Southwestern Med Ctr of Dallas | |||||
Dallas, Texas, United States, 75235 | |||||
Univ of Texas Health Sciences Ctr | |||||
San Antonio, Texas, United States, 78284 | |||||
Houston Clinical Research Network | |||||
Houston, Texas, United States, 77006 | |||||
Univ of Texas / Med School at Houston | |||||
Houston, Texas, United States, 77030 |
Triangle Pharmaceuticals |
Study ID Numbers: | 298B, FTC-301 |
First Received: | November 2, 1999 |
Last Updated: | June 23, 2005 |
ClinicalTrials.gov Identifier: | NCT00002362 |
Health Authority: | United States: Food and Drug Administration |
|
|
|
|
|
|